Volume 20 Issue 12
Dec.  2022
Turn off MathJax
Article Contents
HUANG Ya-fang, GUO Xiang-yu, DU Juan, LIU Yan-li. Factors associated with taking antihypertensive traditional Chinese medicine only among community-dwelling middle-aged and elderly adults[J]. Chinese Journal of General Practice, 2022, 20(12): 2075-2079. doi: 10.16766/j.cnki.issn.1674-4152.002773
Citation: HUANG Ya-fang, GUO Xiang-yu, DU Juan, LIU Yan-li. Factors associated with taking antihypertensive traditional Chinese medicine only among community-dwelling middle-aged and elderly adults[J]. Chinese Journal of General Practice, 2022, 20(12): 2075-2079. doi: 10.16766/j.cnki.issn.1674-4152.002773

Factors associated with taking antihypertensive traditional Chinese medicine only among community-dwelling middle-aged and elderly adults

doi: 10.16766/j.cnki.issn.1674-4152.002773
Funds:

 SM2021100 25003

  • Received Date: 2021-04-16
    Available Online: 2023-02-07
  •   Objective  To investigate the factors associated with antihypertensive traditional Chinese medicine (TCM) intake only among community-dwelling middle-aged and elderly adults in China.  Methods  The analysis was based on the national representative China Health and Retirement Longitudinal Study (CHARLS) in 2018. Community-dwelling adults aged 45 years old or above and who were either taking TCM or western modern medicine (WMM) only were included. Multivariate logistic regression analysis was used to examine the factors associated with taking TCM only for hypertension.  Results  A total of 5 184 patients with hypertension were included, including 312 TCM and 4 872 WMM users. The odds of patients with other types of medical insurances and who used TCM alone was 0.347 times that of patients without medical insurance. The odds of patients in economic development areas of > 000-7 000 and who used TCM alone was 3.197 times that of patients in economic development areas above 000. The odds of obese patients were 0.629 times more than the patients with normal body mass index and who used TCM alone. The odds of patients with self-reported very poor health status and who used TCM alone was 0.331 times that of patients who self-reported very good health status. The odds of patients with more than three types of chronic diseases were 0.167 times more than those with hypertension and used TCM alone. The odds of patients who received TCM for other diseases was 7.271 times that of patients used TCM alone and who were not receiving TCM for other diseases.  Conclusions  Patients in the middle or deprived economic development region, with very good self-reported health status, without other diagnosed chronic disease and under TCM treatment for other diseases are more likely to take TCM for hypertension compared with other patients. In the future, it is necessary to further prospectively observe the difference in the improvement of cardiovascular and cerebrovascular end point outcomes between the two groups of TCM and WMM, so as to provide higher quality evidence for the treatment of hypertension with TCM.

     

  • loading
  • [1]
    TSCHANZ C M P, CUSHMAN W C, HARRELL C T E, et al. Synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: The diagnosis and management of hypertension in the primary care setting[J]. Ann Intern Med, 2020, 173(11): 904-913. doi: 10.7326/M20-3798
    [2]
    LU J P, LU Y, WANG X C, et al. Prevalence, awareness, treatment, and control of hypertension in China: Data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)[J]. Lancet, 2017, 390(10112): 2549-2558. doi: 10.1016/S0140-6736(17)32478-9
    [3]
    BAKRIS G, ALI W, PARATI G. ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison[J]. J Am Coll Cardiol, 2019, 73(23): 3018-3026. doi: 10.1016/j.jacc.2019.03.507
    [4]
    国家心血管病中心国家基本公共卫生服务项目基层高血压管理办公室, 国家基层高血压管理专家委员会. 国家基层高血压防治管理指南2020版[J]. 中国循环杂志, 2021, 36(3): 209-220. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH202103001.htm

    The National Essential Public Health Service Program Office for Management of Hypertension in Primary Health Care. National Clinical Practice Guidelines on the Management of Hypertension in Primary Health Care in China (2020)[J]. Chinese Circulation Journal, 2021, 36(3): 209-220. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH202103001.htm
    [5]
    刘芬, 何毅芳, 谢凡慈, 等. 高血压病患者中医体质特点与心血管疾病危险因素的关联分析[J]. 医学理论与实践, 2021, 34(2): 222-224. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLL202102020.htm

    LIU F, HE Y F, XIE F C, et al. Correlation analysis between TCM constitution characteristics and cardiovascular disease risk factors in hypertensive patients[J]. Medical Theory and Practice, 2021, 34(2): 222-224. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLL202102020.htm
    [6]
    赵倩倩, 李媛媛, 陈聪, 等. 中医药治疗原发性高血压的作用机制研究现状与展望[J]. 中华中医药杂志, 2020, 35(4): 1914-1916. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202004080.htm

    ZHAO Q Q, LI Y Y, CHEN C, et al. Current situation and prospect of the research on the mechanism of TCM in treating essential hypertension[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(4): 1914-1916. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202004080.htm
    [7]
    黄传应, 杨荣, 廖晓阳. 家庭社会支持对高血压治疗依从性影响的研究进展[J]. 中华全科医学, 2021, 19(3): 466-470. doi: 10.16766/j.cnki.issn.1674-4152.001837

    HUANG C Y, YANG R, LIAO X Y. Effects of family social support on treatment compliance of patients with hypertension[J]. Chinese Journal of General Practice, 2021, 19(3): 466-470. doi: 10.16766/j.cnki.issn.1674-4152.001837
    [8]
    ZHAO Y H, HU Y S, SMITH J P, et al. Cohort profile: The China health and retirement longitudinal study (CHARLS)[J]. Int J Epidemiol, 2014, 43(1): 61-68. doi: 10.1093/ije/dys203
    [9]
    VON ELM E, ALTMAN D G, EGGER M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies[J]. PLoS Med, 2007, 4(10): e296. DOI: 10.1371/journal.pmed.0040296.
    [10]
    中国高血压防治指南修订委员会. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56. doi: 10.3969/j.issn.1007-5410.2019.01.002

    Writing Group of 2018 Chinese Guidelines for the Management of Hypertension. 2018 Chinese guidelines for the management of hypertension[J]. Chin J Cardiovasc Med, 2019, 24(1): 24-56. doi: 10.3969/j.issn.1007-5410.2019.01.002
    [11]
    ZHAO Y, ATUN R, OLDENBURG B, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: An analysis of population-based panel data[J]. Lancet Glob Health, 2020, 8(6): e840-e849. DOI: 10.1016/S2214-109X(20)30127-3.
    [12]
    WANG Z W, CHEN Z, ZHANG L F, et al. Status of hypertension in China: Results from the China hypertension survey, 2012-2015[J]. Circulation, 2018, 137(22): 2344-2356. doi: 10.1161/CIRCULATIONAHA.117.032380
    [13]
    郑晨霞, 沈建平. 中医药治疗高血压研究进展[J]. 中医研究, 2021, 34(2): 57-60. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYJ202102020.htm

    ZHENG C X, SHEN J P. Research progress in TCM treatment of hypertension[J]. Traditional Chinese Medicine Research, 2021, 34(2): 57-60. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYJ202102020.htm
    [14]
    WANG Y X, PENG X X, NIE X L, et al. Burden of hypertension in China over the past decades: Systematic analysis of prevalence, treatment and control of hypertension[J]. Eur J Prev Cardiol, 2016, 23(8): 792-800.
    [15]
    HAO P P, JIANG F, CHENG J, et al. Traditional Chinese medicine for cardiovascular disease: Evidence and potential mechanisms[J]. J Am Coll Cardiol, 2017, 69(24): 2952-2966.
    [16]
    ZHANG D Y, CHENG Y B, GUO Q H, et al. Treatment of masked hypertension with a Chinese herbal formula: A randomized, placebocontrolledtrial[J]. Circulation, 2020, 142(19): 1821-1830.
    [17]
    王娅, 刘艳飞, 王哲, 等. 2015-2019年中药治疗原发性高血压的系统评价再评价[J]. 中国循证医学杂志, 2019, 19(12): 1460-1469. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201912013.htm

    WANG Y, LIU Y F, WANG Z, et al. Traditional Chinese medicine treatment for essential hypertension from 2015 to 2019: an overview of systematic reviews[J]. Chinese Journal of Evidence-based Medicine, 2019, 19(12): 1460-1469. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ201912013.htm
    [18]
    周晓丽, 刘曼玲, 焦艳会. 多种慢性病管理模式在社区老年高血压患者中的综合应用与评价[J]. 中华全科医学, 2020, 18(3): 449-453. doi: 10.16766/j.cnki.issn.1674-4152.001270

    ZHAOU X L, LIU M L, JIAO Y H. Comprehensive application and evaluation of multiple chronic disease management models in elderly patients with hypertension in community[J]. Chinese Journal of General Practice, 2020, 18(3): 449-453. doi: 10.16766/j.cnki.issn.1674-4152.001270
    [19]
    张晓娟, 李子锋, 张珺, 等. 常规护理联合多种中医护理技术干预肝阳上亢型高血压合并失眠效果的网状Meta分析[J]. 循证护理, 2020, 6(12): 1285-1291. https://www.cnki.com.cn/Article/CJFDTOTAL-XZHL202012004.htm

    ZHANG X J, LI Z F, ZHANG J, et al. Network Meta-analysis of routine nursing combined with multiple traditional Chinese medicine nursing technology in hypertension patients with hyperactivity of liver-Yang combined with insomnia[J]. Chinese Evidence-based Nursing, 2020, 6(12): 1285-1291. https://www.cnki.com.cn/Article/CJFDTOTAL-XZHL202012004.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Article Metrics

    Article views (227) PDF downloads(15) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return